1351 PREDICTION OF RELAPSE AFTER PEGINTERFERON ALFA-2B/RIBAVIRIN THERAPY IN CHRONIC HCV GENOTYPE 1 PATIENTS IS DEPENDENT ON MINIMAL RESIDUAL VIREMIA BUT NOT ON IL28B GENOTYPE
Journal of Hepatology(2011)
Abstract
Week 4 (log10 decline) Week 12 (log10 decline) <0.5 0.5-1.01.0-2.0>2.0 <2 ≥2.0 ETR 4/31 (13%) 20/53 (38%) 84/100 (84%) 184/192 (96%) 4/57 (7%) 155/176 (88%) SVR 2/4 (50%) 13/20 (65%) 51/84 (61%) 143/184 (78%) 1/4
MoreTranslated text
Key words
chronic hcv genotype,alfa-2b/ribavirin therapy,residual viremia,peginterferon,relapse
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined